Eisai Survey Finds 71% of Endometrial Cancer Patients Prefer to Avoid Further Chemotherapy

PUBT · 1d ago
Eisai Survey Finds 71% of Endometrial Cancer Patients Prefer to Avoid Further Chemotherapy
  • Eisai announced survey findings showing chemotherapy substantially burdens daily life for patients with endometrial cancer.
  • The survey of 119 U.S. patients found most preferred avoiding future chemotherapy and wanted personalized treatment options.
  • Findings will be presented at the ESMO Congress in Madrid on October 26, 2026; additional results were previously presented at SGO.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eisai Co. Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610260700PR_NEWS_USPR_____NY79851) on October 26, 2026, and is solely responsible for the information contained therein.